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BACKGROUND: Hypertension is common among diabetic
patients. The co-existence of two conditions carries an excessive
risk of severe complications and mortalities. Limited information
exists on the determinants of poor hypertension control among
these patients. We aimed at determining the prevalence and factors
associated with poor hypertension control in these patients.
METHODS: Data of diabetic patients who were also hypertensive
attending an outpatient clinic from 1 August 2015 to 31 December
2015 at Bugando Medical Centre were retrospectively analyzed.
Uncontrolled hypertension was defined as a blood pressure of
≥130mmHg and/or ≥80mmHg systolic and diastolic respectively. A
designed questionnaire was used to collect data of patients.
Continuous variables were summarized by median and
interquartile ranges (IQR) and categorical variables were
summarized by frequency and percentage. Logistic regression was
used to find the predictors of uncontrolled hypertension.
RESULTS: The majority of our study population were females,
161/295 (54.6%), and the median age was 57 years (IQR 50-64).
The prevalence of hypertension was 206/295 (69.8%). A total of
174/206 (84.5%) patients had uncontrolled hypertension. This poor
control was significantly associated with poor adherence to antihypertensives (OR 1.73[1.26-2.38] p=0.002), presence of any longterm complication (OR 3.19 [1.65-6.18] p=0.03) and overweight
(BMI>24.9 Vs <24.9) (OR 1.68 [0.98-2.88], p=0.04). Underprescription and ambiguous drugs combination was also observed.
CONCLUSION: The prevalence of poor hypertension control
among diabetic patients in Tanzania is alarming. Most of the
factors associated with this situation can be modified. The
clinicians should advocate individualized management, continuous
health education and adherence to the available guidelines.
KEYWORDS: Uncontrolled hypertension diabetes Tanzania
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INTRODUCTION
There is a growing evidence that the burden of
non-communicable diseases (NCDs) is rapidly
increasing in sub-Saharan Africa (SSA) (1–3).
Estimates of age-standardized mortality suggest
that patients in SSA may have up to three-fold
higher mortality rates than similar European
cohorts for non-communicable diseases. Diabetes
mellitus (DM) and hypertension are common
diseases in Africa with high mortalities (4).
Hypertension, a common comorbid in diabetes,
affects more than 50% of diabetic patients (5–7).
It is clear that the co-existence of these two
conditions in a patient carries an excessive risk
for both micro- and macro-vascular complications,
and mortalities (8). A Framingham study, one of
the largest meta-analysis surveys, showed a strong
association between the two diseases. Coexistence of hypertension in diabetics is attributed
to the risk of death and cardiovascular events by
44% and 41% respectively as compared to 7% and
9% risk by diabetes alone (9).
Blood pressure lowering in diabetic patients
has a remarkable cardiovascular (CV) protective
effect. Guidelines from the Joint National
Committee (JNC-7) and American Diabetes
Association (ADA) recommend maintaining blood
pressure at <130mmHg systolic and <80mmHg
diastolic in patients with diabetes. Usually,
multiple anti-hypertensive agents are needed to
achieve this goal (8,10). In most cases, adequate
control of blood pressure (BP) in these patients is
not attained (5,7,11). Information on the
prevalence, control and risk factors of poor control
of hypertension among diabetic patients in
Tanzania is scarce. The objectives of this study
were to determine the prevalence of hypertension
among diabetics, to evaluate the degree of BP
control, to describe the factors associated with
poor BP control, and to evaluate the patterns of
antihypertensive treatment prescription.
MATERIALS AND METHODS
This cross-sectional study was conducted in a
diabetic clinic at Bugando Medical Centre (BMC).
BMC is the zonal hospital for the Lake Victoria
region in Northwest Tanzania, and it serves a
DOI: http://dx.doi.org/10.4314/ejhs.v27i5.5
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population of approximately 13 million people.
The clinic follows around 1000 diabetic patients
from Mwanza region and referrals from around
the Lake Zone. This study was conducted over a
period of four months starting from August 2015.
Study population: We retrospectively reviewed
clinical records of all patients who were attending
our diabetic clinic from 01 August to 31
December 2015. Patients were excluded if they
were younger than 18 years or pregnant. Patients’
age, gender, occupation, smoking history, duration
of diabetes, history of hypertension, use of
antihypertensive and/or hypoglycemic drugs were
recorded on structured questionnaires. Smoking
history in this study was defined as being either
previous or current smoker. Poor adherence to
medications was defined as a patient’s selfreported use of <80% of the prescribed drugs. This
cut-off is widely acceptable and has been used in
other studies for chronic drugs adherence (12).
Other related clinical information was also
documented. This included height, weight, blood
pressures, Fasting Blood Glucose (FBG),
cholesterol levels, presence of any documented
chronic complication(s) and use of other long term
medications. Body Mass Index (BMI) was
calculated as kg/m2 using the most recent records.
The mean blood pressure from three recent visits
was used to assess the degree of blood pressure
control. Controlled hypertension was defined as
the mean BP of <130/80mmHg. FBG
measurements were also recorded. The mean FBG
from three recent visits was used to define the
Glycemic control. Patients were labeled to have
poor glycemic control when average FBG was
>7.0mmol/L. Glycosylated hemoglobin (HbA1C)
was not done in these patients. The mean FBG of
7.0Mmol/L, which has been used as a cut-off point
in this study, is justified by its correlation to
around 6% HbA1C (13). The mean total
cholesterol level from two recent consecutive
visits was used to define the total cholesterol in
this study.
Ethical statement: The study was approved by
Bugando Medical Centre/ Catholic University of
Health and Allied Sciences (BMC/CUHAS) joint
Committee of Research and Publications.
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Data analysis: Data was entered, verified and
cleaned using Microsoft excel and analysis was
done using STATA version 14 (College Station,
Texas). Continuous variables were summarized by
medians and interquartile ranges (IQRs), and
categorical variables were summarized by
frequency and percentage. Logistic regression was
used to find the predictors of poor blood pressure
control. Comparisons between the two groups
were computed using chi-squared test for
categorical variables, nonparametric Wilcoxon
rank-sum test for continuous variables and student
t-test to compare means between the groups.
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Baseline characteristics of 295 enrolled patients
attending diabetic clinic at BMC: A total of 295
patients attending diabetic clinic at the BMC from
August to December 2015 fulfilled the inclusion
criteria. Among these patients, 161/295 (54.6%)
were females. The median age was 57 years (IQR
50-64). The mean Body Mass Index (BMI) of our
patients was high 27 kg/m2 (IQR 24-30). The
mean duration of diabetes was 48-months (IQR
22-120), and hypoglycemic (anti-diabetic) drugs
were prescribed to all patients. An average FBG
in three consecutive visits was 9.6 (6.9-13.6)
Mmol/dL (Table 1).

RESULTS
Table 1: Baseline characteristics of 295 enrolled diabetic patients attending diabetic clinic at BMC
Characteristic
Sex

Number (%) or median (IQR)
134 (45.4)
161 (54.6)
Age in years
57 (50-64)
BMI (kg/m2)
27 (24-30)
Marital status
Single
5 (1.78)
Married
79 (27.9)
Divorced
145 (51.2)
Widowed
54 (19.0)
Address
Mwanza city
103 (34.9)
Outside of Mwanza city 192 (65.1)
Work status
Informal employment
196(66.7)
Formal employment
76 (25.9)
Retired
22 (7.5)
Smoking history
Yes
32 (10.9)
No
262 (89.1)
Duration of DM (months)
48 (22-120)
Duration on Anti-diabetics (Months)
36 (14-84)
Average FBG (Mmol/dl) (3 consequent visits)
9.6 (6.9-13.6)
Hypertensive
Yes
206 (69.8)
No
89 (43.2)
Possession of any health insurance
Yes
91 (31.2)
No
201 (68.8)
Male
Female

Prevalence of blood pressure control among
diabetic patients attending diabetic clinic at
BMC: Out of 295 diabetic patients attending
diabetic clinic, 206(69.8%) were hypertensive.
The median systolic and diastolic blood pressures
were 140 (120-150) mmHg and 84 (78-89) mmHg

DOI: http://dx.doi.org/10.4314/ejhs.v27i5.5

respectively. A total of 174/206 (84.5%) patients
had uncontrolled BP (≥130/80mmHg).
Characteristics of 206 diabetic patients with
hypertension attending diabetic clinic at BMC:
Table 2 displays the baseline and clinical
characteristics of hypertensive-diabetic patients.
Fifty-six percent of these patients were females.
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Many hypertensive patients, 117 (56.8%), were in
the age group of 51-65 years. Severe hypertension
was seen in 57/206(27.7%) and 40/206(19.4%)
patients for systolic BP ≥ 160mmHg and diastolic
≥ 100mmHg respectively. Nearly 40% of 206 had
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at least one chronic complication related to either
Diabetes and/or hypertension. The most common
complications
reported
were
peripheral
neuropathy, 23(11.2%), stroke, 21(10.2%), and
chronic kidney disease, 16(7.8%).

Table 2: Characteristics of 206 diabetic patients with hypertension attending diabetic clinic at
BMC (n=206).
Characteristic
Sex

Number % or Median (IQR)
Female
Male

116 (56.3)
90 (43.7)
58 (IQR 53-65)

<35
35-50
51-65
>65

8 (3.9)
33 (16.0)
17 (56.8)
48 (23.3)
23 (11.2)
39 (18.9)
56 (27.2)
54 (26.2)
57 (27.7)
43 (20.8)
78 (37.9)
45 (21.8)
40 (19.4)
48 (24-108)
65 (26-120)
57 (27.7)
69 (33.5)
80 (38.3)
4.8 (3.8-6.1)
81 (39.3)
23 (11.2)
21 (10.2)
16 (7.8)
13 (6.3)
4 (1.9)
2 (1.0)
1 (0.5)
114 (59.1)
66 (57.9)
35 (30.7)
12 (10.52)

Age (years)
Age group (years)

Smoking history
Systolic blood pressure(mmHg)

Diastolic blood pressure (mmHg)

Duration of using anti-hypertensives (Months)
Duration of DM (Months)
Average Fasting Blood Glucose (Mmol/dL)

Average total Cholesterol (Mmol/L)
Patients with documented complications
Types of complications documented

Using other long term drugs
Types of drugs used

<120
120-139
140-159
≥160
<80
80-89
90-99
≥100

FBG <7
FBG ≥7≤11
FBG >11

Peripheral neuropathy
Stroke
Chronic Kidney Disease
Retinopathy
Ischemic Heart Disease
Peripheral Vascular Disease
Diabetic Foot Ulcer
Statins
Aspirin
Tricyclic anti-depressants

Predictors of hypertension control among
diabetic patients with hypertension attending
diabetic clinic at BMC: In this study, we found
that poor control of hypertension in diabetic
patients was significantly associated with poor
DOI: http://dx.doi.org/10.4314/ejhs.v27i5.5

adherence to anti-hypertensives (OR 1.73[1.262.38] p=0.002), the presence of any long-term
complication (OR 3.19 [1.65-6.18] p=0.03) and
overweight (BMI>24.9 Vs <24.9) (OR 1.68 [0.982.88], p=0.04). Furthermore, we have also
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demonstrated that poor BP control had a positive
trend in the patients with the age group of 5665years, and those who were residing within the
city with the odds ratio of 2.7 [95% CI, 1.1-06.9]
(p= 0.04) and 3.1[1.1-8.3), p=0.04) respectively in
univariate analysis. These features were not
significant in multivariate analysis (Table 4).
Prescription pattern of anti-hypertensives
among diabetic patients: All, except one patient,
were prescribed on at least one antihypertensive
drug and among them 105 (51.2%), 80 (39.0%)
and 9(4.4%) were on monotherapy, two drugs
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combination and three/more drugs combination
respectively.
Median
duration
on
antihypertensives was 48 months (IQR 24-108).
Types
of
anti-hypertensives
used
were
Angiotensin II converting enzyme Inhibitors
(ACEI) 112 (54.6%) and angiotensin II receptor
blocker (ARB) 62 (30.2%), Calcium channel
blockers (CCB) 92 (44.9%), Beta-Blockers (BB) 8
(3.9%), Diuretics 7 (3.4%) and Hydralazine 6
(2.9%). Details of anti-hypertensives prescription
pattern have been shown in Table 3.

Table 3: Prescription patterns of anti-hypertensives among 205 diabetic patients
Drug

Total (%)
n=205

Monotherapy
105 (51.2%)

Two drugs 80 (39.0%)

Three or more drugs 9 (4.4%)

ACEI
CCB
ARB
BB
Diuretics
Hydralazine

107 (52.2)
92 (44.9)
51 (24.9)
10 (4.9)
8 (3.9)
6 (2.9)

60 (57.1%)
19 (18.1)
17 (16.2%)
0
0
0

ACEI & CCB
ARB & CCB
ACEI & ARB
BB & CCB
CCB & Diuretics
ARB & Diuretics
ACEI & Diuretics

BB, CCB & Hydralazine
ARB, CCB& Diuretics
ACEI, CCB & Hydralazine
BB, Hydralazine & CCB
ACEI, ARB & BB

DISCUSSION
In this study, we found that nearly 70% of diabetic
patients had hypertension and only few (15.5%)
reached their target BP values. Poor adherence to
anti-hypertensive medications, the presence of any
long-term complication and overweight/obesity
significantly
predicted
poor
control
of
hypertension in these patients.
Trends of data collected by the World Health
Organization (WHO) suggest that the number of
people with uncontrolled hypertension has risen
over the recent years, and the highest being in
Africa (30%). The prevalence of diabetes has also
been increasing globally, particularly in middle
and lower income countries (14). These trends
undoubtedly reflect the reported high magnitude
of co-morbidity between the two diseases (11–13).
In Tanzania, Mwita et al reported the prevalence
of hypertension among diabetic patients to be 55%
at Muhimbili National Hospital in 2012(7), where
lower prevalence of 29.3% was reported at the
DOI: http://dx.doi.org/10.4314/ejhs.v27i5.5

35 (43.8)
22 (27.5)
8 (10.0)
5 (6.3)
3 (3.8)
1 (1.3)
1 (1.3)

3 (33.3)
2 (22.2)
2 (22.2)
1 (11.1)
1(11.1)

same center two decades ago (18). In the index
study, we have demonstrated this magnitude to be
much higher (69.8%). This drift clearly suggests a
radical increase of this burden in the country.
We have observed a low rate (15.5%) of
control of hypertension in the index study.
Comparably similar rates have been observed in
Tanzania (34%), Cameroun (10.2%) and Malaysia
(23.5%) (7,15,19). Several randomized trials have
associated significant clinical benefits of tight BP
control among diabetic patients (20–22). In the
United Kingdom Prospective Diabetes Study
(UKPDS), for instance, it was found that each
10mmHg reduction in systolic BP was associated
with average reduction of 15% in diabetes-related
mortalities due to myocardial infarction (11%) and
micro vascular complications (retinopathy and
nephropathy) (13%) (20). Nearly 40% of our
patients already had at least one chronic
complication due to Diabetes/ hypertension/both.

Ethiop J Health Sci.

478

Vol. 27, No. 5

September 2017

Table 4: Logistic regression analysis for predictors of poor control of blood pressure among diabetic
patients with hypertension attending diabetic clinic at BMC
Predictive factor

Sex
Age (years)

BMI
Occupation

Address
Smoking
Possession of
medical
insurance
Duration of DM
(months)
FBG(Mmol/dL)
Average total
cholesterol
(Mmol/dL)
Duration of
antihypertensive
(months)
Type of
antihypertensive

Good adherence
Documented
complications

Number with
controlled BP
(%) n=32
14 (43.8)
18 (56.3)
6 (18.8)
6(18.8)
14 (43.8)
3(9.4)
3(9.4)
28 (87.5)
4 (12.5)
18 (56.3)
12 (37.5)
2(6.3)
5(15.6)
27 (84.4)
2(6.3)
12 (37.5)

Number with
uncontrolled
BP (%) n=174
102 (58.6)
72 (41.4)
42 (24.1)
67(38.5)
46 (26.4)
11(6.3)
8(4.6)
162(93.1)
12 (6.9)
115 (66.5)
41 (23.7)
17 (9.8)
63 (36.2)
111(63.8)
21(12.1)
52 (30.1)

84 (32-120)

62 (26-128.3)

<7
>7
<3.8
3.8-6.1
>6.1

9 (28.13)
23 (71.8)
3 (9.4)
7 (21.9)
22 (68.8)
48 (26-84)

48(27.59)
126 (72.41)
20 (11.5)
37 (21.3)
117 (67.3)
48 (24-108)

ACEI/ARB
CCB
BB
Diuretics
Hydralazine

27 (84.4)
39 (22.4)
1(3.2)
0
0
31 (96.6)

129 (74.1)
15 (46.9)
7 (4.0)
7 (4.0)
6 (3.5)
138 (79.3)

7 (21.9)

74 (42.5)

Female
Male
>65
56-65
46-55
36-45
<36
>24.9
<24.9
Unemployed
Employed
Retired
Mwanza city
Outside Mwanza city

Good adherence to anti-hypertensive medications
among diabetic patients has been associated with
better hypertension control (23) and decreased risk
of CV disease, CV events and mortality (24).
Similar to our findings, adherence to antihypertensives among diabetic patients is generally
poor (25,26). This might be partly caused by
failure of the patients to prevail with increased pile
of drugs to be taken, or potentiated side effects
from both anti-hypertensives and hypoglycemics.
DOI: http://dx.doi.org/10.4314/ejhs.v27i5.5

Unadjusted
OR (95% CI)
value
0.55(0.26-1.17)

P

0.51
0.04
0.05
0.53
0.28
0.02

1.0 (0.6-1.5)

0.86

3.1(1.1-8.3)

0.04

2.1(0.5-9.3)
1.1(.0.6-2.2)

0.35
0.57

1.0 (0.9-1.01)

0.52

0.9 (0.4-2.3)

0.95

1.3(0.4-4.5)
0.9 (0.4-2.4)
0.9 (0.4-2.1)
1.1(1.0-1.2)

0.73
0.93
0.87
0.23

2.64(1.08-6.44)

P

1.7(1.0- 2.9)

0.04

0.12

1.4 (0.5-3.7)
2.7(1.1-6.9)
0.5(0.2-1.0)
0.7(0.2-2.5)
0.5(0.1-1.9)
2.9(1.0-8.0)

0.5 (0.2-1.5)
3.2 (1.3-7.9)
1.3 (0.2-10.6)
*
*
2.13(1.47-3.09)

Adjusted
OR (95%CI)
value

0.22
0.02
0.83
*
*
<0.0 2.12(1.10- 4.08) 0.002
01
0.03 3.19(1.65- 6.18) 0.01

In the case study, we have observed a direct
association between overweight/obesity and poor
control of BP. Similarly, a large Swedish survey
of National Diabetes register which recruited more
than1500 patients demonstrated the same findings.
In this survey, both lower BMI at baseline and
during follow-up had a favorable association for
control of BP (27). Chew et al reported similar
findings in Malaysia (19). A combination of
Diabetes, hypertension and obesity has been
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related with autonomic imbalance and circadian
disruption of the autonomic tones during day and
night periods. These effects may contribute to the
observed findings (28).
Most patients with diabetes require multiple
anti-hypertensive medications to achieve the target
blood pressure. (20,29). A meticulous combination
of anti-hypertensive is therefore desirable. Underprescription of anti-hypertensives was observed in
this study where less than one-half (43.4%) of our
patients were prescribed on two or more antihypertensives. Despite that short-coming, the
majority of our patients were prescribed on ReninAngiotensin system blockers either in combination
with other agents or as a monotherapy. This
prescription pattern is in agreement with several
international guidelines due to their role in
significant reduction of CVD-related deaths,
stroke and delaying deterioration of Glomerular
Filtration Rate (GFR) in patients with Chronic
Kidney
Disease
(CKD)
(8,10,30,31).
Unexpectedly, ACEI with ARB was prescribed in
nine patients. This regime is not recommended as
it does not have any added advantage (32). Human
errors might be the reasons for these incorrect
prescriptions.
In conclusion, the prevalence of poor control
of hypertension among diabetic patients in a
tertiary hospital is high and it is highly predicted
by modifiable factors. Incongruous prescription of
anti-hypertensives is also evident. We believe that
our findings will encourage health care providers
to deliver the health services according to
guidelines and the patient’s individualization.
Importantly, clinicians should endlessly continue
to provide health education on adherence,
preventive measures and control of NCDs. Further
follow-up studies are necessary to ascertain the
long-term outcome of these patients.
This study has limitations. Being a cross
sectional study, the fate of diabetes and
hypertension co-morbidity could not be assessed.
The time from diagnosis of diabetes and
hypertension could also not be evaluated. Despite
these shortcomings, we believe that these findings
are important and relevant as they provide a broad
picture of the situation locally and a baseline
information for further studies on the subject.
DOI: http://dx.doi.org/10.4314/ejhs.v27i5.5
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